SCHEDULE: Agenus Inc. Stakeholder Filing
Beneficial Ownership Filing
Multiple entities and an individual have reported beneficial ownership of Agenus Inc. common stock, totaling 9.99% as of July 13, 2026.
Summary
- Invus Public Equities, L.P., along with associated entities and Raymond Debbane, have collectively reported beneficial ownership of 4,533,755 shares of Agenus Inc. common stock.
- This holding represents 9.99% of the issued and outstanding shares as of July 13, 2026.
- The filing details the ownership structure, including direct holdings of shares and warrants by Invus Public Equities and Avicenna Life Sci Master Fund LP.
- A 'Beneficial Ownership Limitation' restricts the exercise of warrants if it would result in ownership exceeding 9.99% of outstanding shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting ownership stakes and regulatory compliance rather than new financial performance or strategic shifts.
Positives
- Significant stake reported by a group of investors, indicating confidence or strategic interest in Agenus Inc.
- Clear disclosure of beneficial ownership, adhering to regulatory requirements.
Negatives
- The 'Beneficial Ownership Limitation' may restrict the ability to fully exercise warrants, potentially capping upside from warrant holdings.
Risks
- The Beneficial Ownership Limitation could prevent the full exercise of warrants, capping potential gains if the share price increases significantly.
- Potential for future changes in ownership or strategy by the reporting persons.
Future Outlook
The filing does not contain forward-looking statements or guidance. It primarily reports on current beneficial ownership as of a specific date.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant stakeholders in the biotechnology and pharmaceutical sectors, indicating active investment and potential strategic interest in companies like Agenus Inc.
Stakeholder Impact
- Shareholders: The filing provides transparency on significant ownership stakes, which can influence market perception.
- Management: Awareness of substantial beneficial ownership by Invus entities and Raymond Debbane.
Next Steps
- The reporting persons will continue to monitor their beneficial ownership levels in Agenus Inc.
- The Beneficial Ownership Limitation may require adjustments to warrant exercise strategies.
Key Dates
| Date | Description |
|---|---|
| 2026-05-11 | Date of Agenus Inc.'s Quarterly Report on Form 10-Q, which reported 41,642,431 shares outstanding. |
| 2026-07-13 | Date of Event Requiring Filing of Schedule 13G and closing date of a private placement of 1,626,015 shares. |
| 2026-07-15 | Date of closing for a private placement of 1,626,015 shares by Agenus Inc. |
| 2026-07-17 | Date of the Joint Filing Agreement and signatures on the Schedule 13G. |
Keywords
Agenus Inc., Schedule 13G, Beneficial Ownership, Invus Public Equities, Raymond Debbane, Warrants, SEC Filing, Stock Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.